PRIMALung（EORTC-1901）：小细胞肺癌（SCLC）患者的预防性脑照射（PCI）或主动脑磁共振成像（MRI）监测。

IF 4.5 2区医学 Q1 ONCOLOGY

Lung Cancer Pub Date : 2024-10-24 DOI:10.1016/j.lungcan.2024.107993

Antonin Levy , Thierry Berghmans , Michael Koller , Beatrice Fournier , Murielle Mauer , Nicolaus Andratschke , Corinne Faivre-Finn

引用次数: 0

摘要

PRIMALung EORTC-1901 试验研究了所有阶段 SCLC 的脑 MRI 和 PCI，目的是在免疫疗法时代实现非劣效期生存并改善认知。@finn_corinne.

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

PRIMALung (EORTC-1901): PRophylactic cerebral irradiation (PCI) or active brain MAgnetic resonance imaging (MRI) surveillance in small-cell lung cancer (SCLC) patients

The PRIMALung EORTC-1901 trial investigates brain MRI ± PCI in all-stages of SCLC, aiming for non-inferior survival, improve cognition in the era of immunotherapy.

@finn_corinne

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Lung Cancer 医学-呼吸系统

CiteScore

9.40

自引率

3.80%

发文量

407

审稿时长

25 days

期刊介绍： Lung Cancer is an international publication covering the clinical, translational and basic science of malignancies of the lung and chest region.Original research articles, early reports, review articles, editorials and correspondence covering the prevention, epidemiology and etiology, basic biology, pathology, clinical assessment, surgery, chemotherapy, radiotherapy, combined treatment modalities, other treatment modalities and outcomes of lung cancer are welcome.